Reimbursement through the
ACT Program

Accessing Coverage Today

Merck & Co., Inc., knows that health care reimbursement sometimes can make it difficult to access the medications that patients need. To ease the process, we have created the ACT Program to help patients who have been prescribed ZOLINZA, as well as their caregivers.

How to contact ACT

Call 866-363-6379 from 8 am to 8 pm ET, Monday through Friday.

ACT is a 3-part program specifically designed to help patients who have been prescribed ZOLINZA.

Obtaining ZOLINZA

Because ZOLINZA might not be stocked routinely at pharmacies, the ACT Program will arrange to have ZOLINZA delivered to a patient's preferred pharmacy.

Reimbursement Support Services

This is a free program that helps patients and health care providers answer questions related to insurance coverage for ZOLINZA.

Patient assistance

Merck will provide ZOLINZA free of charge to eligible* patients. Eligible patients must complete the Patient Assistance Program enrollment form and send it and the prescription for ZOLINZA to the ACT Program.

*To be eligible, a patient must have an annual gross income at or below 500% of the Federal Poverty Level.

Click below to view or download
the ACT program brochure.

Click below to view or download the
ACT program enrollment form.

Before prescribing ZOLINZA, please read the physician Prescribing Information. The Patient Information also is available.

To view PDF documents, you must have the Adobe Reader installed on your computer.

Back to top